what cbd oil for depression quiz

Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala

RĂ©us GZ, Stringari RB, Ribeiro KF, Luft T, Abelaira HM, Fries GR, Aguiar BW, Kapczinski F, Hallak JE, Zuardi AW, Crippa JA, Quevedo J. Administration of cannabidiol and imipramine induces antidepressant-like effects in the forced swimming test and increases brain-derived neurotrophic factor levels in the rat amygdala.

Objective: Cannabidiol is a chemical constituent from Cannabis sativa and it has multiple mechanisms of action, including antidepressant effects. The main objective of the present study was to evaluate behavioural and molecular effects induced by administration of cannabidiol and imipramine in rats.

Methods: In the present study, rats were acutely or chronically treated for 14 days once a day with saline, cannabidiol (15, 30 and 60 mg/kg) or imipramine (30 mg/kg) and the animals behaviour was assessed in forced swimming and open-field tests. Afterwards, the prefrontal cortex, hippocampus and amygdala brain-derived neurotrophic factor (BDNF) levels were assessed by enzyme-linked immunosorbent sandwich assay.

Results: We observed that both acute and chronic treatments with imipramine at the dose of 30 mg/kg and cannabidiol at the dose of 30 mg/kg reduced immobility time and increased swimming time; climbing time was increased only with imipramine at the dose of 30 mg/kg, without affecting locomotor activity. In addition, chronic treatment with cannabidiol at the dose of 15 mg/kg and imipramine at the dose of 30 mg/kg increased BDNF levels in the rat amygdala.

Conclusion: In conclusion, our results indicate that cannabidiol has an antidepressant-like profile and could be a new pharmacological target for the treatment of major depression.

Elephant at Warsaw Zoo to test cannabis-extract oil

The zoo's four elephants became three in March, following the death of Erna, the largest female and elder of the herd.

Erna's death left Fredzia in mourning, putting her under stress.

Zoo keepers noticed an immediate change in Frezia's behaviour, as she attempted to make sense of life without Erna.

"Fredzia reacted strangely when she saw Erna's body. She was really excited," Dr Agnieszka Czujkowska, head of the zoo's Animal Rehabilitation Department, told the BBC. "But you could see that she was also grieving actually, she was also depressed."

Since then, zoo keepers say Fredzia has displayed signs of stress, as she struggles to establish a new relationship with her female companion, Buba. It can take months or even years for elephants to cope with the loss of an elder and restore a sense of harmony within the herd.

"This is a huge game-changer in every elephant group. Elephants might have behavioural problems when the structure of a group changes," Dr Czujkowska said.

While distressing for Fredzia, this emotional turmoil has presented Warsaw Zoo with an opportunity to test an experimental new treatment.

Dr Czujkowska and her colleagues have launched a project to check whether cannabis-extract oil will reduce anxiety in the zoo's animals.

Cannabidiol, also known as CBD oil, is derived from a cannabis plant compound.

The oil is thought to stimulate the production of serotonin and dopamine, messenger chemicals in the brain, which can help combat depression.

The zoo's elephants will be the first animals to be given the CBD oil, as they are prone to stress and at the same time relatively easy to monitor.

Given her recent behaviour, Fredzia is thought to be the ideal candidate for the study.

"When Erna passed away, everything changed. I don't think Fredzia was ready for such a big change," Dr Czujkowska said.

"Fredzia is always thinking about what Buba is doing now, before that she was more calm."

The first stage of the trial has already been completed. It involved collecting faeces, saliva and blood samples from the elephants to monitor their cortisol levels. Cortisol is a hormone produced in the bodies of humans and animals in stressful situations.

"We are planning to give them the CBD and measure the cortisol again. This is the experiment. Then we know for sure [the oil] is working or not," Dr Czujkowska said.

The CBD oil will be administered directly to the elephants' mouths or mixed in with their food. Their health will be regularly checked through blood tests.

Although derived from cannabis, the oil does not cause any feeling of intoxication. That's because the oil does not contain THC, a psychoactive component of cannabis.

Dr Czujkowska does not expect the elephants to experience any serious side effects.

"It's not very potent. The only side effect will be some behavioural changes," Dr Czujkowska said. "We will have to manage these to achieve the results we want."

Dr Czujkowska said that, to her knowledge, the project was the first of its kind to monitor the cortisol levels of elephants before and after they have taken CBD oil.

CBD products designed for human consumption have been on the market for years in some countries. They are used by some to treat conditions such as pain or insomnia, but regulators have raised safety concerns.